Why join Freenome?
Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.
Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence to drive cancer screening and save lives. Our first screening test is for colorectal cancer (CRC) and advanced adenomas, and it’s just the beginning.
Founded in 2014, Freenome has ~400 employees and continues to grow to match the scope of our ambitions to provide access to better screening and earlier cancer detection.
At Freenome, we aim to impact patients by empowering everyone to prevent, detect, and treat their disease. This, together with our high-performing culture of respect and cross-collaboration, is what motivates us to make every day count.
Become a Freenomer
Do you have what it takes to be a Freenomer? A “Freenomer” is a determined, mission-driven, results-oriented employee fueled by the opportunity to change the landscape of cancer and make a positive impact on patients’ lives. Freenomers bring their diverse experience, expertise, and personal perspective to solve problems and push to achieve what’s possible, one breakthrough at a time.
About this opportunity:
Freenome is looking for a Senior Director, Market Access to bolster our Commercial team. We're looking for a candidate with hands-on Market Access & Reimbursement experience for an in vitro diagnostic (IVD) during the critical launch and early commercialization stages. In this role, you will be instrumental in crafting and executing market access strategies that will be key to the successful commercialization of our products. Your commitment to patient care and access will significantly contribute to our growth and our mission to outpace cancer with early detection.
Reporting directly to the Chief Commercial Officer, this role will serve as a vital part of the Commercial leadership team. There is a preference for this to be Hybrid, based in our Brisbane, California headquarters; however we will consider remote for an exceptional candidate.
What you’ll do:
Market Access & Pricing
- Spearhead the development and execution of market access strategies to enhance patient access, secure reimbursement, and encourage product adoption
- Lead coding, coverage, and pricing initiatives to ensure reimbursement for our CRC screening test upon FDA approval and future product pipeline
- Craft access, reimbursement, and contracting strategies for various payer segments and geographies, aligning with our go-to-market roadmap
- Perform pricing analysis and modeling to establish optimal pricing and contracting that maximizes patient access and revenue
- Identify and build out the appropriate team to support our market access goals
- Collaborate with commercial, finance, and medical teams to develop value propositions, payer messaging, pricing strategies and evidence generation plans that support our market access goals
- Offer strategic leadership on policy issues, access-related market dynamics, and reimbursement
External Engagement
- Monitor and report on healthcare policies, regulations, and trends that affect market access
- Engage with payers, government entities, and stakeholders to inform market access strategies
- Influence healthcare policies and reimbursement practices through engagement with policymakers and advocacy groups
- Conduct market research to understand the payer landscape and policy trends
Cross-Functional Launch Execution
- Lead market access launch readiness, including building out the necessary team to support our go-to-market plan
- Make recommendations for - and potentially drive - our reimbursement and billing operations infrastructure, including both systems and personnel
- Work with internal stakeholders to ensure market access strategies are in sync with business goals
- Develop KPIs to monitor the effectiveness of market access strategies
- Collaborate with Marketing, Legal, and Regulatory Affairs to drive coordinated payer engagement
Other
- Up to 30% travel
Must haves:
- Bachelor's degree
- 10+ years of commercial experience in diagnostics, pharmaceuticals, or biotech; diagnostics experience preferred
- 5+ years in Market Access with direct responsibility for pricing, reimbursement, or policy, especially for early pipeline or launch products
- Experience in IVD or laboratory developed test (LDT) market access
- Experience in cancer or preventative screening, primary care, oncology, and/or consumer sectors
- In-depth knowledge of the healthcare ecosystem, including economics, policy, and the regulatory environment in the U.S
- Familiarity with customer types such as HCPs, patients, payers, IDNs, and their business models
- Proven track record in creating and executing access and reimbursement strategies
- Ability to build pricing and reimbursement models for diagnostics
- Understanding of the revenue cycle for diagnostics within labs, hospitals, and physician settings
- Knowledge of regulatory guidelines and compliance requirements
- Highly collaborative with strong interpersonal skills and relationship-building capabilities
- Entrepreneurial mindset with a proactive approach to problem-solving
- Ability to craft and convey the company’s story compellingly to various audiences
Nice to haves:
- SF Bay Area residency is a plus but not mandatory
- An MBA is advantageous but not essential
- Experience with pricing, coding and coverage for Advanced Diagnostic Laboratory Tests (ADLTs)
- Experience in market research, analysis, or planning in the pharmaceutical, biotechnology, or related industry is beneficial
- Experience leading a reimbursement and billing team is a plus
Benefits and additional information:
The US target range of our base salary rate for new hires is $236,300 - $360,500. You will also be eligible to receive pre-IPO equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
- Family & Medical Leave Act (FMLA)
- Equal Employment Opportunity (EEO)
- Employee Polygraph Protection Act (EPPA)
#LI- Hybrid
What We Do
Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent cancer.
We have pioneered the most comprehensive multiomics platform for early cancer detection through a routine blood draw. By combining deep expertise in molecular biology with advanced computational biology and machine learning techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, we are developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science.
Our recent $270 Million Series C brings our financing to over $500 million from investors, including; Bain Capital, Perceptive Advisors, RA Capital, Polaris Partners, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, Novartis and Verily Life Sciences.